Andreas L Petzer Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

8/2020	A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study.
10/2012	High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.
6/2012	Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
6/2012	Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.
6/2010	High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
11/2003	Hematopoietic stem cells in chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas L Petzer Research Topics

Disease

6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2020 - 11/2003
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2003
3	Neoplasms (Cancer) 10/2017 - 01/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Residual Neoplasm 01/2021
1	Pathologic Complete Response 01/2021
1	Rectal Neoplasms (Rectal Cancer) 05/2020
1	Lymphatic Metastasis 10/2017
1	Carcinoma (Carcinomatosis) 10/2017
1	Renal Insufficiency (Renal Failure) 03/2016
1	AIDS-Related Complex (ARC) 03/2016
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Philadelphia Chromosome 06/2010
1	Hematologic Diseases (Blood Diseases) 09/2007
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2003
1	Blast Crisis (Blast Phase) 06/2002
1	Neoplasm Metastasis (Metastasis) 01/2002
1	Obstructive Sleep Apnea 01/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

4	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 06/2002
3	Tyrosine Kinase InhibitorsIBA 08/2020 - 06/2012
2	tisagenlecleucelIBA 01/2024 - 01/2022
2	L-BLP25IBA 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002 - 01/2002
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Taxoids (Taxanes)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Gemtuzumab (Mylotarg)FDA Link 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2016
1	nilotinib FDA Link 06/2012
1	Blood Group Antigens (Blood Groups)IBA 09/2007
1	Proteins (Proteins, Gene)FDA Link 11/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2003
1	erucylphosphocholineIBA 01/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2009
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
2	Radiotherapy 05/2020 - 07/2009
1	Aftercare (After-Treatment) 01/2020
1	Neoadjuvant Therapy 01/2020
1	Patient Positioning 03/2016
1	Drug Tapering 03/2016
1	Transplantation 01/2016
1	Salvage Therapy 01/2016
1	Cell Transplantation 01/2016
1	Segmental Mastectomy (Lumpectomy) 07/2009
1	Hematopoietic Stem Cell Transplantation 09/2007